2PI0 image
Deposition Date 2007-04-12
Release Date 2007-10-30
Last Version Date 2023-08-30
Entry Detail
PDB ID:
2PI0
Title:
Crystal Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-B enhancer
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.31 Å
R-Value Free:
0.26
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Interferon regulatory factor 3
Gene (Uniprot):IRF3
Chain IDs:C (auth: A), D (auth: B), E (auth: C), F (auth: D)
Chain Length:116
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polydeoxyribonucleotide
Molecule:PRDIII-I region of human interferon-B promoter strand 1
Chain IDs:A (auth: E)
Chain Length:32
Number of Molecules:1
Biological Source:
Polymer Type:polydeoxyribonucleotide
Molecule:PRDIII-I region of human interferon-B promoter strand 2
Chain IDs:B (auth: F)
Chain Length:32
Number of Molecules:1
Biological Source:
Primary Citation
Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer.
Mol.Cell 26 703 716 (2007)
PMID: 17560375 DOI: 10.1016/j.molcel.2007.04.022

Abstact

Interferon regulatory factor 3 (IRF-3) is a key transcription factor in the assembly of the mammalian interferon-beta (IFN-beta) enhanceosome. We present here the structure of IRF-3 DNA binding domain in complex with the complete PRDIII-I regulatory element of the human IFN-beta enhancer. We show that four IRF-3 molecules bind in tandem to, variably spaced, consensus and nonconsensus IRF sites on the composite element. The ability of IRF-3 to bind these variable sites derives in part from two nonconserved arginines (Arg78 and Arg86) that partake in alternate protein-DNA contacts. We also show that the protein-DNA contacts are highly overlapped and that all four IRF sites are required for gene activation in vivo. In addition, we show that changing the nonconsensus IRF sites to consensus sites creates a more efficient enhancer in vivo. Together, the structure and accompanying biological data provide insights into the assembly of the IFN-beta enhanceosome in mammals.

Legend

Protein

Chemical

Disease

Primary Citation of related structures